Awesome Medical Company, LLC

ProteoGenex Corporation is a privately held US company founded in Los Angeles in 2003. Headquarter in Culver City, California, along with a large state research laboratory in Moscow, Russia, with 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, Pathologists ( 15 PhDs, 5 MDs, 15 MSs ). ProteoGenex offers an access to the extensive Biorepository as well as to the exclusive custom designed human tissue-based research service, which is the company's largest and fastest growing business segment. Our unique broad Biobank is composed of well-defined and categorized clinical samples, including tissues, blood, serum, bone marrow, tissue microarrays, and etc. These samples are collected from a network of academic and professional clinical institutions under strict ethical standards. ProteoGenex collects biomaterials covering such disease targets as Oncology, Dermatology, Neurology, Immunology, Infectious diseases, Autoimmune and Metabolic disorders. Our products are derived from a variety of diseased human sources as well as from normal tissues and supported by pathology information and patient's clinical history documentation.

Polypeptide Laboratories is a global leader in the production and development of peptides, offering a wide range of services including GMP compliance, process optimization, and custom research grade peptides. With manufacturing sites in Europe, the USA, and Asia, the company provides commercial manufacturing solutions and specializes in the production of generic peptides, radiolabeled peptides, and individualized peptides for various industries. With a strong focus on quality assurance and regulatory support, Polypeptide Laboratories is committed to delivering high-quality products and services to its clients. The company's expertise in peptide synthesis and its state-of-the-art facilities make it a trusted partner for pharmaceutical, cosmetic, and research organizations worldwide.Generated from the website

Bionaut Labs Inc. is at the forefront of precision micro-technology, specializing in the development of microscale robots designed to deliver biologics and small molecule therapies directly to targeted areas within the human body. Their innovative approach focuses on removing barriers to localized treatment and diagnostic detection for severe brain disorders, including neuro-oncology and neurodegeneration. Utilizing advanced magnetic propulsion systems, Bionauts navigate complex three-dimensional trajectories with precision, ensuring accurate access to intricate regions of human anatomy. Each procedure is meticulously planned and executed, allowing for effective interventions that can significantly enhance patient outcomes. Generated from the website